-
Something wrong with this record ?
Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR)
A. Carazo Fernández, T. Smutny, L. Hyrsová, K. Berka, P. Pavek,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Cell Line MeSH
- Cytochrome P-450 CYP2B6 metabolism MeSH
- ErbB Receptors drug effects MeSH
- Phenobarbital pharmacology MeSH
- Flavanones pharmacology MeSH
- Flavonoids pharmacology MeSH
- Hepatocytes drug effects metabolism MeSH
- Humans MeSH
- ets-Domain Protein Elk-1 drug effects genetics MeSH
- Receptors, Cytoplasmic and Nuclear agonists MeSH
- Protein Transport drug effects MeSH
- Binding Sites drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The constitutive androstane receptor (CAR) is a crucial transcriptional regulator of key xenobiotic-metabolizing enzymes such as cytochrome P450 CYP3A4, CYP2C9 and CYP2B6. The flavonoids chrysin, baicalein and galangin have been reported to activate CAR and interfere with EGFR signaling. Nevertheless, it is not known if these flavonoids are direct CAR ligands or indirect phenobarbital-like CAR activators via the inhibition of epidermal growth factor receptor (EGFR) signaling. We analyze the interactions of chrysin, galangin and baicalein and its glycoside baicalin with human CAR. We have employed and validated methods that can study direct interaction with the CAR ligand binding pocket. Secondly, we determined if the compounds affect human EGFR signaling and interact with EGFR. Employing a TR-FRET coactivator assay with recombinant CAR or CAR assembly assay, a consistent activation of CAR with flavonoids and phenobarbital was not observed. It was determined, however, that galangin, chrysin, and baicalein may slightly repress EGFR-Tyr1068 autophosphorylation after EGF treatment, phosphorylation of downstream transcription factor ELK1 and stimulate EGFP-CAR nuclear translocation in primary human hepatocytes. These data suggest that flavonoids chrysin, galangin and baicalein are indirect human CAR activators. This study also demonstrates new approach how to test the direct CAR interaction with its ligands.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022847
- 003
- CZ-PrNML
- 005
- 20150723103738.0
- 007
- ta
- 008
- 150709s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.toxlet.2015.01.013 $2 doi
- 035 __
- $a (PubMed)25625231
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Carazo Fernández, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic.
- 245 10
- $a Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR) / $c A. Carazo Fernández, T. Smutny, L. Hyrsová, K. Berka, P. Pavek,
- 520 9_
- $a The constitutive androstane receptor (CAR) is a crucial transcriptional regulator of key xenobiotic-metabolizing enzymes such as cytochrome P450 CYP3A4, CYP2C9 and CYP2B6. The flavonoids chrysin, baicalein and galangin have been reported to activate CAR and interfere with EGFR signaling. Nevertheless, it is not known if these flavonoids are direct CAR ligands or indirect phenobarbital-like CAR activators via the inhibition of epidermal growth factor receptor (EGFR) signaling. We analyze the interactions of chrysin, galangin and baicalein and its glycoside baicalin with human CAR. We have employed and validated methods that can study direct interaction with the CAR ligand binding pocket. Secondly, we determined if the compounds affect human EGFR signaling and interact with EGFR. Employing a TR-FRET coactivator assay with recombinant CAR or CAR assembly assay, a consistent activation of CAR with flavonoids and phenobarbital was not observed. It was determined, however, that galangin, chrysin, and baicalein may slightly repress EGFR-Tyr1068 autophosphorylation after EGF treatment, phosphorylation of downstream transcription factor ELK1 and stimulate EGFP-CAR nuclear translocation in primary human hepatocytes. These data suggest that flavonoids chrysin, galangin and baicalein are indirect human CAR activators. This study also demonstrates new approach how to test the direct CAR interaction with its ligands.
- 650 _2
- $a vazebná místa $x účinky léků $7 D001665
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a cytochrom P450 CYP2B6 $x metabolismus $7 D065702
- 650 _2
- $a flavanony $x farmakologie $7 D044950
- 650 _2
- $a flavonoidy $x farmakologie $7 D005419
- 650 _2
- $a hepatocyty $x účinky léků $x metabolismus $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a fenobarbital $x farmakologie $7 D010634
- 650 _2
- $a transport proteinů $x účinky léků $7 D021381
- 650 _2
- $a erbB receptory $x účinky léků $7 D066246
- 650 _2
- $a receptory cytoplazmatické a nukleární $x agonisté $7 D018160
- 650 _2
- $a protein Elk-1 s doménou ets $x účinky léků $x genetika $7 D050807
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Smutny, Tomas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic.
- 700 1_
- $a Hyrsová, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic.
- 700 1_
- $a Berka, Karel $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry Palacky University in Olomouc, 17. listopadu 1131, Olomouc CZ779 00, Czech Republic.
- 700 1_
- $a Pavek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic. Electronic address: petr.pavek@faf.cuni.cz.
- 773 0_
- $w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 233, č. 2 (2015), s. 68-77
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25625231 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150723103814 $b ABA008
- 999 __
- $a ok $b bmc $g 1083186 $s 905840
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 233 $c 2 $d 68-77 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
- LZP __
- $a Pubmed-20150709